Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway

Lehe Yang1,2,3, Jifa Li1, Lingyuan Xu1,2,3

  • 1Department of Respiratory Medicine, Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325600, People's Republic of China, zhaochengguang@wmu.edu.cn, 873331666@qq.com.

Abstract

Insights

Rhein effectively combats non-small-cell lung cancer (NSCLC) by inhibiting the IL-6/STAT3 pathway, showing promise as a novel antitumor agent.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Non-small-cell lung cancer (NSCLC) is a prevalent cancer with poor prognosis, often diagnosed at advanced stages.
  • The Interleukin-6/Signal Transducer and Activator of Transcription 3 (IL-6/STAT3) pathway is crucial in NSCLC development.
  • Rhein, a natural compound from medicinal herbs, exhibits potential antitumor properties.

Purpose of the Study:

  • To investigate the anti-proliferative and pro-apoptotic effects of Rhein on NSCLC.
  • To elucidate the mechanism of Rhein's action, focusing on the IL-6/STAT3 pathway.
  • To evaluate the in vivo efficacy of Rhein in NSCLC models.

Main Methods:

  • Assessed Rhein's impact on NSCLC cell viability, colony formation, apoptosis, and cell cycle progression using cell-based assays.
  • Analyzed protein expression levels of STAT3, apoptosis regulators (Bcl-2, Bax), and cell cycle proteins (MDM2, CDC2, P53, CyclinB1) via Western blotting.
  • Evaluated Rhein's anti-tumor effect in vivo using NSCLC xenograft models.

Main Results:

  • Rhein significantly reduced NSCLC cell viability and induced apoptosis in a dose-dependent manner.
  • Rhein inhibited STAT3 phosphorylation, upregulated Bax, and downregulated Bcl-2 expression.
  • Rhein caused G2/M cell cycle arrest and inhibited tumor growth in xenograft models.

Conclusions:

  • Rhein demonstrates potent anti-NSCLC activity by inhibiting the STAT3 signaling pathway.
  • Rhein effectively suppresses NSCLC proliferation and induces apoptosis.
  • Rhein holds promise as a potential novel therapeutic agent for NSCLC treatment.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
219
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.1K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K